Dossier Obesity | Observatoire de la prévention de l'Institut de Cardiologie de Montréal

Cardiovascular benefits associated with body weight loss

5 December 2023

|

The results of clinical studies on new anti-obesity drugs confirm that significant body weight loss is associated with a reduced risk of cardiovascular disease.

Emulsifiers: Food additives that increase the risk of cardiovascular disease?

26 October 2023

|

Dr Martin Juneau, M.D., FRCP

High consumption of certain emulsifiers widely used in the manufacture of ultra-processed foods is associated with an increased risk of cardiovascular disease.

Preventing cardiovascular disease also means preventing cancer!

1 June 2023

|

Dr Martin Juneau, M.D., FRCP

One study reports that people who have cardiovascular disease are at much higher risk of developing several types of cancers in the years that follow.

Akkermansia muciniphila: An essential bacterium for maintaining good health

27 March 2023

|

Dr Martin Juneau, M.D., FRCP

Akkermansia muciniphila, a bacterium that colonizes the mucus layer of the intestinal wall, contributes to the maintenance of this protective layer and generates metabolites that have several beneficial effects on metabolism and immunity.

Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity

2 March 2023

|

Dr Martin Juneau, M.D., FRCP

Initially developed to treat patients with type 2 diabetes, these drugs also cause significant weight loss and are establishing themselves as the first truly effective pharmacological treatments for obesity.